Inventor · disambiguated record
Matthew During
Also filed as: DURING MATTHEW · DURING MATTHEW J · DURING MATTHEW JOHN
70 granted patents·81 pending applications·1,349 citations·filing 1993–2025
99Inventor score
Files withOVID THERAPEUTICS INC113NEUROLOGIX INC8UNIV JEFFERSON5UNIV OXFORD INNOVATION LTD3UNIV ROCKEFELLER3
Top patents by PatentIndex Score
151 records- 0199US11395817B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2020·Granted Jul 26, 2022·8 cites·31 claims
- 0299US10799485B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2020·Granted Oct 13, 2020·8 cites·20 claims
- 0399US10603308B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2019·Granted Mar 31, 2020·17 cites·13 claims
- 0499US9446028B2Methods of increasing tonic inhibition and treating fragile X syndrome and angelman syndromeOVID THERAPEUTICS INC·Filed 2016·Granted Sep 20, 2016·26 cites·8 claims
- 0598US9682069B2Methods of treating Dravet syndromeOVID THERAPEUTICS INC·Filed 2016·Granted Jun 20, 2017·19 cites·7 claims
- 0698US9351968B1Methods of treating developmental disorders using pipradrolOVID THERAPEUTICS INC·Filed 2015·Granted May 31, 2016·24 cites·4 claims
- 0798US9339495B2Methods of increasing tonic inhibition and treating secondary insomniaOVID THERAPEUTICS INC·Filed 2015·Granted May 17, 2016·26 cites·6 claims
- 0898US6180613B1AAV-mediated delivery of DNA to cells of the nervous systemUNIV ROCKEFELLER·Filed 1995·Granted Jan 30, 2001·488 cites·15 claims
- 0997US10363246B1Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2019·Granted Jul 30, 2019·13 cites·5 claims
- 1097US10071083B2Use of gaboxadol in the treatment of tinnitusOVID THERAPEUTICS INC·Filed 2018·Granted Sep 11, 2018·11 cites·15 claims
- 1197US9801864B2Methods of increasing tonic inhibition and treating secondary insomniaOVID THERAPEUTICS INC·Filed 2016·Granted Oct 31, 2017·7 cites·6 claims
- 1297US9744159B2Methods of treatment Rett syndromeOVID THERAPEUTICS INC·Filed 2016·Granted Aug 29, 2017·9 cites·13 claims
- 1397US6503888B1AAV-mediated delivery of DNA to cells of the nervous systemUNIV ROCKEFELLER·Filed 2000·Granted Jan 7, 2003·140 cites·26 claims
- 1496US9717716B2Methods of sedation during critical care treatmentOVID THERAPEUTICS INC·Filed 2016·Granted Aug 1, 2017·16 cites·30 claims
- 1596US9399034B1Methods of sedation during critical care treatmentOVID THERAPEUTICS INC·Filed 2015·Granted Jul 26, 2016·20 cites·10 claims
- 1694US10188635B2Use of gaboxadol in the treatment of tinnitusOVID THERAPEUTICS INC·Filed 2018·Granted Jan 29, 2019·5 cites·15 claims
- 1794US9913833B2Methods of treating developmental disorders using pipradrolOVID THERAPEUTICS INC·Filed 2017·Granted Mar 13, 2018·4 cites·4 claims
- 1893US11291658B2Use of gaboxadol in the treatment of diabetes and related conditionsOVID THERAPEUTICS INC·Filed 2020·Granted Apr 5, 2022·2 cites·16 claims
- 1993US10653652B2Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addictionOVID THERAPEUTICS INC·Filed 2019·Granted May 19, 2020·5 cites·7 claims
- 2093US2025025448A1Methods of increasing tonic inhibition and treating secondary insomniaOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2192US7638120B2High transgene expression of a pseudotyped adeno-associated virus typeUNIV JEFFERSON·Filed 2003·Granted Dec 29, 2009·34 cites·11 claims
- 2292US6329181B1Helper functions for recombinant vector productionNEUROLOGIX INC·Filed 2000·Granted Dec 11, 2001·37 cites·45 claims
- 2392US2024415817A1Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2492US2025025449A1Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2591US10813918B2Use of Gaboxadol in the treatment of diabetes and related conditionsOVID THERAPEUTICS INC·Filed 2018·Granted Oct 27, 2020·3 cites·15 claims
- 2691US9610261B2Methods of treating Prader-Willi SyndromeOVID THERAPEUTICS INC·Filed 2016·Granted Apr 4, 2017·3 cites·10 claims
- 2791US7955595B2Glutamic acid decarboxylase (GAD) based delivery systemNEUROLOGIX INC·Filed 2010·Granted Jun 7, 2011·9 cites·6 claims
- 2891US6436708B1Delivery system for gene therapy to the brainFiled 1998·Granted Aug 20, 2002·197 cites·18 claims
- 2990US11918563B1Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2023·Granted Mar 5, 2024·0 cites·16 claims
- 3090US6780409B2Glutamic acid decarboxylase (GAD) based delivery systemUNIV JEFFERSON·Filed 2001·Granted Aug 24, 2004·21 cites·14 claims
- 3189US11903930B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2023·Granted Feb 20, 2024·0 cites·20 claims
- 3289US11806336B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2023·Granted Nov 7, 2023·0 cites·41 claims
- 3389US11096929B2Methods of treating developmental disorders with gaboxadolOVID THERAPEUTICS INC·Filed 2018·Granted Aug 24, 2021·3 cites·13 claims
- 3489US10195165B2Methods of treating Prader-Willi syndromeOVID THERAPEUTICS INC·Filed 2017·Granted Feb 5, 2019·2 cites·10 claims
- 3587US10765646B2Methods of treating developmental encephalopathiesOVID THERAPEUTICS INC·Filed 2018·Granted Sep 8, 2020·2 cites·12 claims
- 3687US10111865B2Methods of sedation during critical care treatmentOVID THERAPEUTICS INC·Filed 2017·Granted Oct 30, 2018·2 cites·23 claims
- 3787US9827233B1Methods of treating behavioral syndromes using pipradrolOVID THERAPEUTICS INC·Filed 2017·Granted Nov 28, 2017·4 cites·3 claims
- 3887US5601835APolymeric device for controlled drug delivery to the CNSMASSACHUSETTS INST TECHNOLOGY·Filed 1994·Granted Feb 11, 1997·92 cites·14 claims
- 3986US12144801B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2022·Granted Nov 19, 2024·0 cites·18 claims
- 4085US12465597B2Methods of treating developmental disorders with gaboxadolOVID THERAPEUTICS INC·Filed 2022·Granted Nov 11, 2025·0 cites·1 claims
- 4185US12109201B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2022·Granted Oct 8, 2024·0 cites·21 claims
- 4285US2023051859A1Methods of increasing tonic inhibition and treating secondary insomniaOVID THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4384US10870855B2Use of MIR101 or MIR128 in the treatment of seizure disordersOVID THERAPEUTICS INC·Filed 2018·Granted Dec 22, 2020·1 cites·19 claims
- 4484US10704048B2Use of MIR-92A or MIR-145 in the treatment of Angelman syndromeOVID THERAPEUTICS INC·Filed 2019·Granted Jul 7, 2020·1 cites·29 claims
- 4584US10420773B2Methods of treating developmental disorders and/or seizure disorders with etifoxineOVID THERAPEUTICS INC·Filed 2018·Granted Sep 24, 2019·1 cites·8 claims
- 4684US2024173280A1Methods of treating seizure disorders and prader-willi syndromeOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4783US6503887B1Peroral gene therapy of diabetes and obesityDURING MATTHEW·Filed 2000·Granted Jan 7, 2003·20 cites·39 claims
- 4881US7655619B2Insulin-associated peptides with effects on cerebral healthUNIV JEFFERSON·Filed 2003·Granted Feb 2, 2010·22 cites·23 claims
- 4981US2024252447A1Pharmaceutical formulations containing gaboxadol for therapeutic treatmentOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 5081US2022016091A1Methods of increasing tonic inhibition and treating secondary insomniaOVID THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 151 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →